← Back

Shanghai Haixin Group Co Ltd A

Shanghai Haixin Group Co., Ltd. manufactures and sells pharmaceutical products in China and internationally. It also leases industrial park properties, engages in financial investment and commodity trading, and produces and sells chemical drugs through its sales platform or local distributors. In addition, the company researches, develops, produces, and sells plush fabrics and clothing, and offers property and value-added services. Founded in 1986, it is headquartered in Shanghai, China.

Price · split & dividend adjusted
News & notes moving 600851.CG
600851.CG4

Haixin Group's 2026 interim net profit reaches 129 million yuan, up 20.30% year on year

Haixin Group released its 2026 interim report, with net profit attributable to the parent company of 129 million yuan, up 20.30% from the same period last year, marking three consecutive years of growth. The company's total operating revenue was 312 million yuan, down 16.22% year on year. Net cash flow from operating activities was negative 58.1093 million yuan, down 169.64% from the same period last year. The company's latest asset-liability ratio was 16.24%, gross margin was 64.39%, and diluted earnings per share was 0.11 yuan.
Jiemian·29dRead more →